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Introduction
Griscelli syndrome (GS) is a rare autosomal recessive disorder characterized by hypopigmentation of the skin and hair, the presence of large clumps of pigment in hair shafts and an accumulation of mature melanosomes within the melanocytes (1) . These pigmentary features are specific for patients with GS and can be distinguished from the hypopigmentation observed in other disorders such as Chediak-Higashi and HermanskyPudlak syndromes. Griscelli syndrome was first described as the combination of an immune disorder to this hypopigmentation. Most GS patients develop an uncontrolled T lymphocyte and macrophage activation syndrome (known as the "accelerated phase" or hemophagocytic syndrome) which may lead to secondary neurological impairment. In contrast, other patients develop a primary severe neurological impairment in the absence of apparent immune abnormalities. Defects in two different genes, MYO5A and RAB27A, are thought to be responsible for GS type 1 and 2 (GS1 and GS2) phenotypes, respectively (2, 3) .
In GS1 the characteristic hypopigmentation is combined with a severe primary neurological impairment which arises early in life. These patients carry mutations in the myosin 5A gene (MYO5A), which encodes an organelle motor protein (myosin Va) with a critical role in neuron function. In contrast, hypopigmentation in GS2 is associated with Here, we report on a preterm neonate with GS-typical hypopigmentation and who presented with respiratory distress and intracerebral hemorrhage. A mutation in the melanophilin gene was found and so GS3 was diagnosed. Since GS3 is restricted to 5 hypopigmentation, no treatment was needed. The preterm delivery, respiratory distress and intracerebral hemorrhage were not attributable to hemophagocytic syndrome and were unrelated to GS3.
Patient presentation
We report on a Saudi-Arabian boy, now aged 19 months. He was born to consanguineous healthy parents (first degree cousins). There was no history of childhood death or suspected immunodeficiency in the family. Due to premature rupture of the fetal membranes, the neonate was delivered after 30 weeks of gestation. The weight was 1010 g (10 th percentile for gestational age), length 38 cm (10 th percentile) and head circumference 26 cm (just below the 10 th percentile). Due to infant respiratory distress syndrome, the baby was taken to a neonatal intensive care unit and received mechanical ventilation for 58 days. A grade II intraventricular, cerebral hemorrhage and a grade IV hematoma (both on the left hand side) were diagnosed by ultrasonography at the chronological age of 9 days. Hemostatic plasma parameters and blood cell counts were normal. The patient did not have fever, lymphadenopathy or hepatosplenomegaly.
Regularly performed neurological assessments showed normal muscle tone, gross motor activities and cognitive functions. A computed tomography (CT) scan of the brain at the age of 7 months showed no shift of the brain midline structures and no signs of recent intracranial hemorrhage. There was evidence of mild lateral ventricle asymmetry that could have resulted from the previous hemorrhage. At the chronological age of 10 months, the child had a developmental age of 8 months.
The boy had silvery-gray hair and fair skin as shown in Figure 1 B. He was admitted to the Immunology department for suspected GS. Light microscopy examination of his hair showed large clumps of pigment irregularly distributed along the 7 hair shaft (Fig. 1 C) . There were no episodes suggestive of hemophagocytic syndrome.
Segregation of microsatellite markers in the family excluded the RAB27A/MYO5A locus but was compatible with the MLHP locus. Genomic DNA sequencing revealed a novel, homozygous mutation in MLHP exon 7 (delC986) leading to a frame shift and L344X (Figure 2 A) . Both parents were heterozygous. The L344 residue is located in the myosinbinding domain of melanophilin (Figure 2 B) .
Informed consent for the present study and publication of the photographs were been obtained from the child's parents and the work was approved by the local independent ethics committee.
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Discussion
Here, we report on a boy with a new homozygous mutation in the melanophilin gene which resulted in GS3, where the GS phenotype is limited to hypopigmentation. This is the second case of GS3 reported. Our preterm born patient had GS-characteristic hypopigmentation, was suffering from infant respiratory distress syndrome and had radiological signs of intraventricular hemorrhage. He recovered from the respiratory distress and did not show any neurological sequelae at the age of 8 months. Characteristic hypopigmentation is a shared feature in individuals with GS1, GS2, and GS3. In GS1, hypopigmentation is combined with a severe neurological impairment and muscle hypotonia at onset. Primary mental retardation and regressive neurological disorders have been described (4). The child described here did not show any of these clinical signs and his mental development was normal.
Griscelli syndrome type 2 is associated with an immune disease which results in episodes of a life-threatening hemophagocytic syndrome that necessitate treatment with immunosuppressive agents. In GS2, the age at the first episode of hemophagocytic syndrome varies. Hemophagocytic syndromes can occur in the neonatal period and may be associated with preterm delivery (5). Thus, GS2-associated hemophagocytic syndrome represents an important differential diagnosis in a the patient with GS-characteristic hypopigmentation, preterm delivery, respiratory distress and intraventricular hemorrhage, such as the case reported here. It is clear that prematurity per se is not related to GS1 or GS3; however, it can be associated with hemophagocytosis and thus GS2.
In GS2, the only curative treatment for the immune disease is hematopoietic stem cell transplantation. Early diagnosis and transplantation are essential for a positive outcome in GS2 patients and it has been suggested that pre-emptive transplantation, i.e.
before the occurrence of the hemophagocytic syndrome should be preferred. We diagnosed GS3 in the patient presented here. Preterm delivery, distress and intraventricular hemorrhage were not associated with a hemophagocytic syndrome. 
